Screener
Eligibility screening
Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
3 US sites in FL, TN, TX
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.